Disease progression, drug action and Parkinson's disease: why time cannot be ignored.
Holford
Nick
N
Department of Pharmacology and Clinical Pharmacology, University of Auckland, Auckland, New Zealand. n.holford@auckland.ac.nz
Nutt
John G
JG
D000978:Antiparkinson Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D018450:Disease Progression; D006801:Humans; D007980:Levodopa / Q000494:pharmacology / Q000627:therapeutic use*; D008954:Models, Biological; D010300:Parkinson Disease / Q000188:drug therapy*; D013997:Time Factors
D000978:Antiparkinson Agents; D007980:Levodopa